Comparative Study of Remnant Cholesterol, Some Lipid Fractions and FBS Level in Overweight and Obese Participants in South East Nigeria
Asian Journal of Research in Biochemistry, Volume 12, Issue 3,
Page 11-19
DOI:
10.9734/ajrb/2023/v12i3235
Abstract
Background: Obesity is one of the characteristics of metabolic disorders, it has been linked to cardiovascular diseases. Remnant cholesterol has been proposed to be a link between obesity and coronary heart disease, thus a risk factor for the development of cardiovascular disease in obese people. We compared the level of calculated non-fasting remnant cholesterol, fasting and non-fasting lipid profile and fasting blood sugar in overweight, obese and normal weight participants in Nnewi, a town in South East Nigeria.
Methods: In this cross-sectional study, a total of 90 apparently healthy obese, overweight and normal weight participants who met the inclusion criteria were randomly enrolled. They were grouped using their body mass index of 18.5 to 24.9 kg/m2 (normal weight), 25 to 29.9 kg/m2 (overweight) and ≥30 kg/m2 (obese). The parameters were analyzed using standard methods.
Results: Our results shows that there was progressive increase of remnant cholesterol among the group, this increase has no statistical difference (p>0.05) in the mean calculated remnant cholesterol (mmol/l) between the obese (0.72±0.4), overweight (0.68±0.46), and normal weight (0.50±0.28) participants. The mean fasting Very Low Density Lipoprotein (VLDL) and Triglyceride (TG) (mmol/l) were significantly higher (p<0.05) in overweight compared to normal weight participants (0.76±0.31 vs. 0.47±0.22) and (1.72±0.60 vs. 1.09±0.51) and obese participants (0.82±0.23 vs. 0.47±0.22) and (1.85±0.59 vs. 1.09±0.51) when compared to normal weight participants respectively. FBS levels (mmol/l) were significantly lower in normal weight participants when compared to overweight participants (3.45±0.79 vs. 4.46±1.82) and obese participants (3.46± 0.79 vs. 4.94±1.26).
Conclusion: The results obtained from this study demonstrated a progressive increase in the level of remnant cholesterol which was not statistically significant among apparently healthy individuals across the group. Furthermore we did not observed Remnant cholesterol as a sole predictor to obesity which will lead to cardiovascular diseases, with the rising prevalence of obesity in developing country as well as its associated complications and risks.
- Remnant cholesterol
- obesity
- BMI
- cardiovascular disease
- lipid profile
How to Cite
References
Finkelstein EA, Brown DS, Trogdon JG, Segel JE, Ben-Joseph RH. Age-specific impact of obesity on prevalence and costs of diabetes and dyslipidemia. Value in Health. 2007; 10(SUPPL. 1):S45-S51. DOI:https://doi.org/10.1111/j.1524-4733.2006.00154.x
Ogden CL, Yanovski SZ, Carroll MD, Flegal KM. The epidemiology of obesity. Gastroenterology. 2007;132: 2087–2102.
Varbo A, Benn M, Davey Smith G, Timpson NJ, Tybjaerg-Hansen A, Nordestgaard BG. Remnant cholesterol, low density lipoprotein cholesterol, and blood pressure as mediators from obesity to ischemic heart disease. Circulation Research. 2015;116:665–73.
Nwachukwu Daniel C, Uchenna Francis Agu, Nkiru Zuada Nwachukwu. Pattern of renal impairment among hypertensive subjects in Umuahia, South East, Nigeria. International Journal of Medicine and Medical Sciences. 2016;8.5:45-50. DOI:https://doi.org/10.5897/IJMMS2016.1229
Drewnowski A, Specter SE. Poverty and obesity: The role of energy density and energy costs. American Journal of Clinical Nutrition. 2004;79:6‑16.
Sola AO, Steven AO, Kayode JA, Olayinka AO. Underweight, overweight and obesity in adults Nigerians living in rural and urban communities of Benue State. Annals of African Medicine. 2011;10:139‑43.
Ayodele OE, Akinboro AO, Akinyemi SO, Adepeju AA, Akinremi OA, Alao CA, Popoola AA. Prevalence and clinical correlates of metabolic syndrome in Nigerians living with human immunodeficiency virus / acquired immunodeficiency syndrome. Metab Syndr Relat Disord. 2012 Oct;10(5):373-9. DOI: 10.1089/met.2012.0050. Epub 2012 Jul 16. PMID: 22799758.
Ono T, Guthold R, Strong K. WHO global comparable estimates. Global Infobase data for saving lives; 2005. Available:https://apps.who.int/infobase/Index.aspx
Babu SV, Jagadeesan AR, Ramalingam J. A comparative study of lipid profile in obese and non-obese men attending master health checkup. Indian Journal of Medical Biochemistry. 2017;21(2):73-75.
Copinschi G, Leproult R, Spiegel K. The important role of sleep in metabolism. Front Hormonal Research. 2014;42:59–72.
Akarolo-Anthony SN, Willett WC, Spiegelman D, Adebamowo CA. Obesity epidemic has emerged among Nigerians. BioMedical Central Public Health. 2014;14:455.
Amole IO, OlaOlorun AD, Odeigah LO, Adesina SA. The prevalence of abdominal obesity and hypertension amongst adults in Ogbomosho, Nigeria. African Journal of Primary Health Care. Family Medicine. 2011;3(1).
Ulasi II, Ijoma CK, Onodugo OD. A community–based study of hypertension and cardio–metabolic syndrome in semi–urban and rural communities in Nigeria. Bio-Med Central of Health Service and Research. 2010;19(10):71.
World Health Organisation. The world health report: Reducing risks, promoting healthy lifestyles. Geneva; 2002.
Criqui MH, Golom BA. Epidemiologic aspects of lipid abnormalities. American Journal of Medicine. 2013;105(Suppl 1A):48S–57S.
Dallinga-Thie GM, Kroon J, Boren J, Chapman MJ. Triglyceride-rich lipoproteins and remnants: Targets for therapy?. Current Cardiology Reports. 2016;18(7):67.
Allen CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total Serum Cholesterol. Clinical Chemistry. 1974;20:470-475.
Denke MA, Sempos CT, Grundy SM. Excess body weight. An underrecognized contributor to high blood cholesterol levels in white American men. Arch International Medicine. 1993;153(9): 1093-103.
Varbo A, Freiberg JJ, Nordestgaard BG. Remnant cholesterol and mayocadial infarction in normal weight, overweight, and obese individuals from copenhangen general population study. Clinical Chemistry. 2018;64(1):219-230.
Zheng et al. Prevalence and epidemiological determinants of metabolically obese but normal-weight in Chinese population. BMC Public Health. 2020;20:487.
Nnamdi JJ Chinonso, Amah UK, Onuegbu JA, Okpara HC, Okwara JE, Olisekodiaka JM, Analike RA, Izuchukwu EC. Comparative study of the level of atherogenic markers; remnant cholesterol, Non-HDLc, total cholesterol-HDLc ratio and LDLc-HDLc ratio, in overweight and obese subjects in Nnewi South East Nigeria. Asian Journal of Cardiology Research, 2021;5(3):42-49:Article no.AJCR.75546.
Kinosian B, Glick H, Garland G. Cholesterol and coronary heart disease: predicting risks by levels and ratios. Annals of Internal Medicine. 2019;121:641–647.
Jorgensen AB, Frikke-schmidt R, West AS, Grand P, Nordestgaard BG, Tybearg-Hansen A. Genetically elevated non-fasting triglyceride and calculated cholesterol as a casual risk factor for myocardial infarction. European Heart Journal. 2013;34(24):1826-1833.
Moraes JC, Coope A, Morari J, Cintra DE, Roman EA, Pauli JR, Romanatto T, Carvalheira JB, Oliveira AL, Saad MJ, et al. High-fat diet induces apoptosis of hypothalamic neurons. PLoS ONE. 2009;4:e504.
Rifai N, Warnick GR. Lipids lipoproteins, apolipoproteins and other cardiovascular risk factors. In: Burtis CA, Ashwood ER, Bruns DE. Tietz Text Book of Clinical Chemistry, 4th edition vol 3. Hsevier Saunders. 2006;26:903-981.
Mora S. Nonfasting for routine lipid testing: From evidence to action. Journal of American Medical Association Internal Medicine. 2016;176 (7):1005–6.
Mach F, Baigent C, Catapano A, et al. ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). European Heart Journal. 2019;41:1:111-188.
Keaven M. Anderson, Patricia M. Odell, Peter WF. Wilson, William B. Kannel. Cardiovascular disease risk profiles. American Heart Journal. 1991;121(1):Part 2:293-298. ISSN 0002-8703, DOI:https://doi.org/10.1016/0002-8703(91)90861-B
Young DS, Bermes EW. Preanalytical variables and biological variation. In: Burtis CA, Ashwood ER, Bruns DE. Tietz Text Book of Clinical Chemistry, 4th edition. Hsevier Saunders. 2006;17(2):449- 473.
Finkelstein E, Fiebelkorn I, Wang G. National medical spending attributable to overweight and obesity: how much and who is paying. Health aff. (millwood). 2003;3:219-26.
Friedwald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clinical Chemistry. 1972;18(6):499-502.
Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Annals of Clinical Biochemistry. 1969;6-24.
Al-shareefi AN, et al Assessment of insulin resistant and related cardio-metabolic factors in overweight-obese women presented with missed abortion, Baghdad, Iraq. Saudi Journal of Obesity. 2015;3:66-77.
Manninen V, Tenkanen L, Koskinen P, et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment. Circulation. 2014;85:37–45.
Gupta M, Mukherjee R. study on the comparative study of serum leptin and lipid profile among non-diabetic obese subjects and type 2 diabetes patients due to obesity. Biochemistry Indian Journal. 2018;12(3):132.
Haddad NIA. Nori E, Hamza SA. Serum visfatin and chemerin levels in Iraqi diabetics and obese individuals. RJPBCS. 2017;8(6):356-64.
Zavorini I. Dall’aglio E, Alpi O, et al. Evidence for an independent relationship between plasma insulin and concentration of high density lipoprotein cholesterol and triglyceride. Atherosclerosis. 1985 ;55:259-66.
Varbo A, Benn M, Nordestgaard BG. Remnant cholesterol as a cause of ischemic heart disease: evidence, definition, measurement, atherogenicity, high risk patients, and present and future treatment. Pharmacol Ther. 2014 Mar;141(3):358-67. DOI: 10.1016/j.pharmthera.2013.11.008. Epub 2013 Nov 26. PMID: 24287311.
Ugwuja E et al. Overweight and obesity, lipid profile and athrogenic indices among civil servants in abakiliki, south east Nigeria. Annals of Medical and Health Sciences Research. 2013;3(1):13-18.
Nakajima K, Nakano T, Tanaka A. The Oxidative Modification hypothesis of Atherosclerosis: the comparison of atherogenic effects on oxidized LDL and remnant lipoprotein in the plasma. Clinical Chemistry Acta. 2006;367:37-47.
Wang Kexin, Ding Yaodong†, Gao Wen, Wang Rui, Yang Jiaxin, Liu Xiaoli, Shen Hua, Ge Hailong. Association of increased remnant cholesterol and the risk of coronary artery disease: A retrospective study. Front. Cardiovasc. Med. 2021;8: 740596. DOI: 10.3389/fcvm.2021.740596.
Castañer O, Pintó X, Subirana I, Amor AJ, Ros E, Hernáez Á, et al. Remnant cholesterol, not LDL cholesterol, is associated with incident cardiovascular disease. J Am Coll Cardiol. 2020;76:2712–24. DOI: 10.1016/j.jacc.2020.10.008.
Langsted A, Madsen CM, Nordestgaard BG. Contribution of remnant cholesterol to cardiovascular risk. J Intern Med. 2020; 288:116–27. DOI: 10.1111/joim.13059.
Amodu PH, Mba IO, Lawson L. Prevalence of obesity and dyslipidemia in hypertensive in Abuja Nigeria. Scandinavia Journal of Clinical Laboratory Investigation. 2005; 240:14-7.
Xie et al. Remnant cholesterol is an independent predictor of new-onset diabetes: a single-center cohort study diabetes, metabolic syndrome and obesity: Targets and Therapy. 2021;14 4735–4745.
Masuoka H, Kamei S, wagayama H, Ozaki M, Kawasaki A, Tanaka T, Kitamura M, Katoh S, Shintani U, Misaki M, Sugawa M, Ito M, Nakano T. Assiociation of remnant-like particle cholesterol with coronary artery disease in patients with normal cholesterol total cholesterol levels”. American Heart Journal. 2000;139(2 pt 1): 305-310.
Li W, Huang Z, Fang W, Wang X, Cai Z, Chen G, Wu W, Chen Z, Wu S, Chen Y. Remnant cholesterol variability and incident ischemic stroke in the general population. Stroke. 2022 Jun;53(6):1934-1941. DOI: 10.1161/STROKEAHA.121.037756. Epub 2022 May 11. PMID: 35543132.
Amira CO, Sokunbi DOB, Dolapo D, Sokunbi A. Prevalence of obesity, overweight and proteinuria in an urban community in South West Nigeria. Nigerian Medical Journal. 2011; 52(2):110–113.
Lopez JP, Juan B, Sandra M, Rueda Q, Cristina LL, Camilo F. Obesity and preeclampsia; common pathophysiological mechanism. Frontiers in Physiology. 2018;9-1838.
-
Abstract View: 38 times
PDF Download: 23 times
